Results 201 to 210 of about 642,758 (265)

External quality assessment program for human papillomaviruses DNA testing in Thailand. [PDF]

Pract Lab Med
Okada PA, Mitrat S, Rojanawiwat A.
europepmc   +1 more source

Metabolic and Fluid Biomarkers Support Microglia Activation in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis is an incurable neurodegenerative disease involving motor neuron degeneration and metabolic and immune dysfunction. We combined clinical data, cerebrospinal fluid biomarkers and fluorodeoxyglucose positron emission tomography with magnetic resonance imaging to investigate the role of reactive microglia in disease ...
Matteo Zanovello, Francesca Serani, Alen Bebeti, Federica Paredi, Giulia Quadrio, Andrea Fortuna, Giacomo Maria Minicuci, Elena Pegoraro, Annachiara Cagnin, Diego Cecchin, Gianni Sorarù   +10 more
wiley   +1 more source

Performance Evaluation of Molecular Detection of Enteroviruses: Results of 18 Years of Quality Control for Molecular Diagnostics (QCMD) External Quality Assessment Program, 2005-2022. [PDF]

J Med Virol
Benschop KSM, Staines H, Mckloud E, McCulloch E, Montgomery D, Sutton G, Donoso Mantke O, van Loon A.   +7 more
europepmc   +1 more source

Quantitative Evaluation of the Real-World Harmonization Status of Laboratory Test Items Using External Quality Assessment Data. [PDF]

Ann Lab Med
Kim S, Jeong TD, Lee K, Chung JW, Cho EJ, Lee S, Chun S, Song J, Min WK.   +8 more
europepmc   +1 more source

Identification methods as a factor affecting the performance of clinical microbiology laboratories participating in an external quality assessment program: a cross-sectional, retrospective analysis. [PDF]

J Med Microbiol
Wu J, Alam MS, Restelli V, Vimalanathan S, Perrone LA.   +4 more
europepmc   +1 more source

The Path to Clinical Implementation of <italic>DPYD</italic> Pharmacogenetic Testing: Long-Term Experience from an External Quality Assessment Provider and a University Testing Center.

Oncol Res Treat
Hedtke M, Ast V, Leidheiser J, Kessler A, Neumaier M, Hofheinz RD, Haselmann V.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lipid external quality assessment: commutability between external quality assessment and clinical specimens

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2008
Background Targets for cholesterol reduction are part of the Quality Outcomes Framework and general practitioners have to meet these targets to fulfil their remuneration package. By contrast, there are no targets for the accuracy of cholesterol or other lipid measurements and no recent surveys on performance of ...
Cramb R, French J, Mackness M, Neely RDG, Caslake M, MacKenzie F   +5 more
openaire   +3 more sources

Advantages of external quality assessment‐EQA programs

Haemophilia, 2022
AbstractIntroductionThe first external quality assessment (EQA) in Thrombosis and Haemostasis was elaborated over 20 years ago, and since then, several national and international EQA institutions have been established.AimDisplay the benefits of EQA programs.MethodsThe spectrum of EQA action was evaluated ranges from improving the performance of the ...
Silmara Aparecida de Lima Montalvão, Anna Lowe, Steve Kitchen   +2 more
openaire   +2 more sources

External quality assessment: best practice

Journal of Clinical Pathology, 2014
There is a requirement for accredited laboratories to participate in external quality assessment (EQA) schemes, but there is wide variation in understanding as to what is required by the laboratories and scheme providers in fulfilling this. This is not helped by a diversity of language used in connection with EQA; Proficiency testing (PT), EQA schemes,
David, James, Darren, Ames, Berenice, Lopez, Rachel, Still, Wiliam, Simpson, Patrick, Twomey   +5 more
openaire   +2 more sources

External quality assessment (EQA) for CoaguChek monitors

Thrombosis and Haemostasis, 2010
SummaryAnticoagulant control facilities are being overwhelmed by requests for monitoring and large numbers of patients are not therefore receiving treatment. Procedures designed for point-of-care testing have therefore been developed, the most popular being the CoaguChek.
J. Jespersen, L. Poller, A. M. van den Besselaar, F. J. van der Meer, G. Palareti, A. Tripodi, C. Shiach, M. Keown, S. Ibrahim   +8 more
openaire   +5 more sources